magnifying glass
logo for SAB Biotherapeutics

SAB Biotherapeutics

Get Full Access

Description

SAB Biotherapeutics is a clinical-stage, biopharmaceutical company developing a new class of immunotherapies leveraging fully human polyclonal antibodies. SAB h... Read More

Headquarters

Headquarters:

2100 East 54th Street North, Sioux Falls, South Dakota, 57104, United States
Phone

Phone:

(605) 679-6980
Employees

Employees:

131
Revenue

Revenue:

$49 Million
SIC Code 87,873
NAICS Code 541,541714
Popular Searches:

SAb Biotherapeutics Inc

sab biotherapeutics , inc.

SAb Biotherapeutics

SAB Biotherapeutics Inc.

Top Competitors of SAB Biotherapeutics

Employess
42
revenue
$14 Million

1

Employess
<25
revenue
<$5 Million

2

Employess
50
revenue
$9 Million

3

Employess
43
revenue
<$5 Million

4

Employess
<25
revenue
<$5 Million

5

Employess
47
revenue
<$5 Million

6

SAB Biotherapeutics's Org Chart

Eddie Sullivan
Eddie Sullivan

Co-Founder, President & Chief Execu...

PhonePhoneEmailEmail
Kipp Erickson
Kipp Erickson

Chief Operating Officer

PhonePhoneEmailEmail
Russell Beyer
Russell Beyer

Chief Financial Officer

PhonePhoneEmailEmail

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

SAB Biotherapeutics Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateRoundAmountInvestors

Jul 17, 2020

Series D

$36M

-

Apr 27, 2020

Debt

$350K

PPP

Dec 20, 2018

Series A

$22M

-

See More

$63M

Total Funding Amount

$36M

Most Recent Funding Amount

5

Number of Funding Rounds

Revenue
QuarterRevenue

'20 - Q3

14740000

'20 - Q4

14740000

'21 - Q1

14740000

'21 - Q2

14740000

Acquisitions & Subsidiaries

Sep 02, 2021

Big Cypress Acquisition

See More Acquisitions & Subsidiaries

SAB Biotherapeutics's Tech Stack

Google Analytics

By

Google

Google Global Site Tag

By

Google

Google Cloud Platform

By

Google

Microsoft PowerPoint

By

Microsoft

Microsoft Project

By

Microsoft

Office 365

By

Microsoft
See more technologies

SAB Biotherapeutics News & Media

SAB Biotherapeutics Reports Positive Phase 2 Virology Data Demonstrating SAB-185 Met Criteria for Advancement to Phase 3 in NIH ACTIV-2 Trial for Treatment of COVID-19

SAB-185 is being evaluated in Phase 3 NIH-Sponsored ACTIV-2 COVID trial of high-risk patients following positive DSMB review of interim Phase 2 safety and efficacy data in September

SAB Biotherapeutics to Present at 2022 H.C. Wainwright BioConnect Virtual Conference

SIOUX FALLS, S.D., Jan. 05, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), (SAB), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced that Eddie J. Sullivan, PhD, co-founder, president, and CEO, will present at the H.C. Wainwright BioConnect Virtual Conference occurring January 10-13, 2022. The presentation will be availa

SAB Biotherapeutics Added to NASDAQ Biotechnology Index

SIOUX FALLS, S.D., Dec. 20, 2021 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, today announced that it has been selected for addition to the NASDAQ Biotechnology Index®, effective prior to market open on Monday, December 20, 2021.
Subscribe to "SAB Biotherapeutics" News

Frequently Asked Questions regarding SAB Biotherapeutics

Where are SAB Biotherapeutics’s headquarters?

SAB Biotherapeutics’s headquarters are in 2100 East 54th Street North, Sioux Falls, South Dakota, 57104, United States

What is SAB Biotherapeutics’s phone number?

SAB Biotherapeutics’s phone number is (605) 679-6980

What is SAB Biotherapeutics’s official website?

SAB Biotherapeutics’s official website is //www.sabbiotherapeutics.com

What is SAB Biotherapeutics’s Revenue?

SAB Biotherapeutics’s revenue is $49 Million

What is SAB Biotherapeutics’s SIC code?

SAB Biotherapeutics’s SIC: 87,873

What is SAB Biotherapeutics’s NAICS code?

SAB Biotherapeutics’s NAICS: 541,541714

How many employees are working in SAB Biotherapeutics?

SAB Biotherapeutics has 131 employees

What is SAB Biotherapeutics’s industry?

SAB Biotherapeutics is in the industry of: Biotechnology, Pharmaceuticals, Healthcare

Who are SAB Biotherapeutics’s main competitors?

SAB Biotherapeutics's main competitors are: BioLineRx, AvantGen, BioXcel Therapeutics, Pandion Therapeutics

What companies has SAB Biotherapeutics acquired?

SAB Biotherapeutics has acquired the companies: Big Cypress Acquisition

What is SAB Biotherapeutics's tech stack?

The technologies that are used by SAB Biotherapeutics are: Google Analytics, Google Global Site Tag, Google Cloud Platform, Microsoft PowerPoint

Who is SAB Biotherapeutics's CEO?

SAB Biotherapeutics's CEO is Eddie Sullivan

Who is SAB Biotherapeutics's CFO?

SAB Biotherapeutics's CFO is Russell Beyer

See more information about SAB Biotherapeutics

Browse ZoomInfo’s Directories